ARISTEA THERAPEUTICS, INC.

Profile

Company Names

ARISTEA THERAPEUTICS, INC.

Addresses

12770 HIGH BLUFF DRIVE, SUITE 380, SAN DIEGO, CA 92130

Phone Numbers

858-987-4064

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2018

State Incorporated:

DELAWARE

Total Amount Raised:

$63,120,980.00

Number of Funding Rounds:

1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2020-10-06 
$63,120,980.00 
$63,120,986.00 
$6.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
TIBA 
 
AYNECHI 
DIRECTOR
THESAN PHARMACEUTICALS, INC.   |  IRHYTHM TECHNOLOGIES, INC.   |  ANAPTYSBIO INC   |  GENOA PHARMACEUTICALS, INC.   |  MIRUM PHARMACEUTICALS, INC.   |  ARCELLX, INC.   |  NKARTA, INC.   |  AVALYN PHARMA INC.   |  SPRUCE BIOSCIENCES, INC.   |  ARISTEA THERAPEUTICS, INC.   |  MBX BIOSCIENCES, INC.   |  REZO THERAPEUTICS, INC.   |  RAY THERAPEUTICS, INC.
KENNETH 
 
HARRISON 
DIRECTOR
EDGEWISE THERAPEUTICS, INC.   |  CLARIS BIOTHERAPEUTICS, INC.   |  RENEO PHARMACEUTICALS, INC.   |  ARISTEA THERAPEUTICS, INC.
CIARA 
 
KENNEDY 
DIRECTOR
LUMENA PHARMACEUTICALS, INC.   |  AMPLYX PHARMACEUTICALS, INC.   |  ARISTEA THERAPEUTICS, INC.
JAMES 
 
MACKAY 
EXECUTIVE OFFICER, DIRECTOR
ARISTEA THERAPEUTICS, INC.   |  ARTHROSI THERAPEUTICS, INC.   |  MATRISYS BIOSCIENCE, INC.   |  RESOLUTE SCIENCE, INC.
LORETTA 
 
TSE 
DIRECTOR
ARISTEA THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2021-08-05
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-10-06 
2020-10-20
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-10-06 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#